2018-24485. Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 8, 2019.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

    In accordance with 21 CFR 1301.33(a), this is notice that on August 2, 2018, Chattem Chemicals, 3801 Saint Elmo Avenue, Chattanooga, Tennessee 37409-1237 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    4-Methoxyamphetamine7411I
    Dihydromorphine9145I
    Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Hydrocodone9193II
    Levorphanol9220II
    Methadone9250II
    Methadone intermediate9254II
    Morphine9300II
    Oripavine9330II
    Thebaine9333II
    Oxymorphone9652II
    Noroxymorphone9668II
    Start Printed Page 56104
    Tapentadol9780II
    Fentanyl9801II

    The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers.

    In reference to drug code 7360 (marihuana) and 7370 (tetrahydrocannabinols) the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Dated: October 25, 2018.

    John J. Martin,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-24485 Filed 11-8-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
11/09/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2018-24485
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 8, 2019.
Pages:
56103-56104 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-24485.pdf